Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 154

1.

Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage.

Zeineddine HA, Girard R, Cao Y, Hobson N, Fam MD, Stadnik A, Tan H, Shen J, Chaudagar K, Shenkar R, Thompson RE, McBee N, Hanley D, Carroll T, Christoforidis GA, Awad IA.

J Magn Reson Imaging. 2017 Aug 9. doi: 10.1002/jmri.25831. [Epub ahead of print]

PMID:
28791783
2.

Using a brain electrical activity biomarker could aid in the objective identification of mild Traumatic Brain Injury patients.

Naunheim R, Covassin T, Jacquin A, Hanley D, Michelson E.

Am J Emerg Med. 2017 Jul 3. pii: S0735-6757(17)30515-6. doi: 10.1016/j.ajem.2017.07.007. [Epub ahead of print] No abstract available.

PMID:
28709713
3.

Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial.

Murthy SB, Awad I, Harnof S, Aldrich F, Harrigan M, Jallo J, Caron JL, Huang J, Camarata P, Lara LR, Dlugash R, McBee N, Eslami V, Hanley DF, Ziai WC; CLEAR III Trial Investigators.

Neurology. 2017 Jul 25;89(4):355-362. doi: 10.1212/WNL.0000000000004155. Epub 2017 Jun 28.

PMID:
28659429
4.

Does contrast between eggshell ground and spot coloration affect egg rejection?

Dainson M, Hauber ME, López AV, Grim T, Hanley D.

Naturwissenschaften. 2017 Aug;104(7-8):54. doi: 10.1007/s00114-017-1476-2. Epub 2017 Jun 22.

PMID:
28642972
5.

A brain electrical activity (EEG) based biomarker of functional impairment in traumatic head injury: a multisite validation trial.

Hanley D, Prichep LS, Badjatia N, Bazarian J, Chiacchierini RP, Curley KC, Garrett JS, Jones EB, Naunheim R, O'Neil BJ, O'Neill J, David W, Huff JS.

J Neurotrauma. 2017 Jun 9. doi: 10.1089/neu.2017.5004. [Epub ahead of print]

PMID:
28599608
6.

Adaptive Enrichment Designs for Stroke Clinical Trials.

Rosenblum M, Hanley DF.

Stroke. 2017 Jul;48(7):2021-2025. doi: 10.1161/STROKEAHA.116.015342. Epub 2017 May 23. Review. No abstract available.

PMID:
28536178
7.

Motor recovery beginning 23 years after ischemic stroke.

Sörös P, Teasell R, Hanley DF, Spence JD.

J Neurophysiol. 2017 Aug 1;118(2):778-781. doi: 10.1152/jn.00868.2016. Epub 2017 May 17.

PMID:
28515288
8.

Restarting Anticoagulant Therapy After Intracranial Hemorrhage: A Systematic Review and Meta-Analysis.

Murthy SB, Gupta A, Merkler AE, Navi BB, Mandava P, Iadecola C, Sheth KN, Hanley DF, Ziai WC, Kamel H.

Stroke. 2017 Jun;48(6):1594-1600. doi: 10.1161/STROKEAHA.116.016327. Epub 2017 Apr 17. Review.

PMID:
28416626
9.

Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial.

Fam MD, Hanley D, Stadnik A, Zeineddine HA, Girard R, Jesselson M, Cao Y, Money L, McBee N, Bistran-Hall AJ, Mould WA, Lane K, Camarata PJ, Zuccarello M, Awad IA.

Neurosurgery. 2017 Apr 10. doi: 10.1093/neuros/nyx123. [Epub ahead of print]

PMID:
28402516
10.

Multispectral images of flowers reveal the adaptive significance of using long-wavelength-sensitive receptors for edge detection in bees.

Vasas V, Hanley D, Kevan PG, Chittka L.

J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2017 Apr;203(4):301-311. doi: 10.1007/s00359-017-1156-x. Epub 2017 Mar 17.

11.

PItcHPERFeCT: Primary Intracranial Hemorrhage Probability Estimation using Random Forests on CT.

Muschelli J, Sweeney EM, Ullman NL, Vespa P, Hanley DF, Crainiceanu CM.

Neuroimage Clin. 2017 Feb 15;14:379-390. doi: 10.1016/j.nicl.2017.02.007. eCollection 2017.

12.

Vorapaxar and Amyotrophic Lateral Sclerosis: Coincidence or Adverse Association?

Serebruany VL, Fortmann SD, Hanley DF, Kim MH.

Am J Ther. 2017 Mar/Apr;24(2):e139-e143. doi: 10.1097/MJT.0000000000000395. Review.

PMID:
28267691
13.

Demographic Risk Factors for Vascular Lesions as Etiology of Intraventricular Hemorrhage in Prospectively Screened Cases.

Fam MD, Pang A, Zeineddine HA, Mayo S, Stadnik A, Jesselson M, Zhang L, Dlugash R, Ziai W, Hanley D, Awad IA; CLEAR III Trial Investigators.

Cerebrovasc Dis. 2017;43(5-6):223-230. doi: 10.1159/000458452. Epub 2017 Feb 28.

PMID:
28245439
14.

Egg discrimination along a gradient of natural variation in eggshell coloration.

Hanley D, Grim T, Igic B, Samaš P, López AV, Shawkey MD, Hauber ME.

Proc Biol Sci. 2017 Feb 8;284(1848). pii: 20162592. doi: 10.1098/rspb.2016.2592.

15.

Emergency Department Triage of Traumatic Head Injury Using a Brain Electrical Activity Biomarker: A Multisite Prospective Observational Validation Trial.

Hanley D, Prichep LS, Bazarian J, Huff JS, Naunheim R, Garrett J, Jones EB, Wright DW, O'Neill J, Badjatia N, Gandhi D, Curley KC, Chiacchierini R, O'Neil B, Hack DC.

Acad Emerg Med. 2017 May;24(5):617-627. doi: 10.1111/acem.13175. Epub 2017 Mar 31.

PMID:
28177169
16.

Erratum: Medical and Surgical Advances in Intracerebral Hemorrhage and Intraventricular Hemorrhage.

Ziai W, Carhuapoma JR, Nyquist P, Hanley DF.

Semin Neurol. 2017 Feb;37(1):103-104. doi: 10.1055/s-0037-1598083. Epub 2017 Feb 1. No abstract available.

PMID:
28147425
17.

Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial.

Hanley DF, Lane K, McBee N, Ziai W, Tuhrim S, Lees KR, Dawson J, Gandhi D, Ullman N, Mould WA, Mayo SW, Mendelow AD, Gregson B, Butcher K, Vespa P, Wright DW, Kase CS, Carhuapoma JR, Keyl PM, Diener-West M, Muschelli J, Betz JF, Thompson CB, Sugar EA, Yenokyan G, Janis S, John S, Harnof S, Lopez GA, Aldrich EF, Harrigan MR, Ansari S, Jallo J, Caron JL, LeDoux D, Adeoye O, Zuccarello M, Adams HP Jr, Rosenblum M, Thompson RE, Awad IA; CLEAR III Investigators.

Lancet. 2017 Feb 11;389(10069):603-611. doi: 10.1016/S0140-6736(16)32410-2. Epub 2017 Jan 10.

PMID:
28081952
18.

Improving precision by adjusting for prognostic baseline variables in randomized trials with binary outcomes, without regression model assumptions.

Steingrimsson JA, Hanley DF, Rosenblum M.

Contemp Clin Trials. 2017 Mar;54:18-24. doi: 10.1016/j.cct.2016.12.026. Epub 2017 Jan 4.

PMID:
28064029
19.

Inequality in treatment benefits: Can we determine if a new treatment benefits the many or the few?

Huang EJ, Fang EX, Hanley DF, Rosenblum M.

Biostatistics. 2017 Apr 1;18(2):308-324. doi: 10.1093/biostatistics/kxw049.

PMID:
28025183
20.

Primary intraventricular hemorrhage in adults: etiological causes and prognostic factors in Chinese population.

Zhang S, Jia B, Li H, You C, Hanley DF, Jiang Y.

J Neurol. 2017 Feb;264(2):382-390. doi: 10.1007/s00415-016-8367-x. Epub 2016 Dec 20.

PMID:
28000008

Supplemental Content

Loading ...
Support Center